ArticleBMC health services research2026
The patient's voice: real-world experiences of a transthyretin amyloidosis focus group.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTransthyretin amyloidosis (ATTR) is a progressive, multisystemic disorder that severely impacts patient quality of life. Despite therapeutic advancements, significant delays in diagnosis and care persist, often due to insufficient awareness among healthcare professionals. We aimed to highlight the experiences of patients living with ATTR in Spain in order to understand their daily challenges within the healthcare system.
methodsAs part of the CARABELA-ATTR initiative, we conducted a focus group discussion with six patients with confirmed ATTR from different regions of Spain. The discussions explored three main areas: (1) communication and coordination between healthcare professionals and patients; (2) patient education, focusing on awareness, knowledge, and engagement; and (3) emotions, quality of life, and living with the disease, which explored the physical and emotional impacts of ATTR.
resultsParticipants reported significant challenges, including diagnosis and treatment delays, fragmented care due to poor coordination between specialists, and barriers to accessing treatments and care, both financial and administrative. The physical and psychological toll of the disease was explored. Patients who received multidisciplinary care at specialized centres reported more positive experiences, emphasizing the importance of coordinated care and timely interventions.
conclusionsThis study amplifies patients’ voices to underscore their unmet needs in the current ATTR care pathway, including increased awareness, earlier diagnosis, enhanced coordination among specialists, and equitable access to specialized care. Integrating mental health support and patient education into care plans is critical for improving the well-being of ATTR patients. These findings advocate for a more patient-centred, comprehensive approach to ATTR care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.